Advanced search
Publication Cover
Future Oncology Volume 14, 2018 - Issue 14
Submit an article Journal homepage
3,391
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Recent Breakthroughs in Metastatic Uveal Melanoma: A Cause for Optimism?

Joseph J Sacco1 Liverpool Ocular Oncology Research Group, Department of Molecular & Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, UK;2 Department of Medical Oncology, Clatterbridge Cancer Centre, Bebington, UK
,
Helen Kalirai1 Liverpool Ocular Oncology Research Group, Department of Molecular & Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, UK
,
Jenna Kenyani1 Liverpool Ocular Oncology Research Group, Department of Molecular & Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, UK
,
Carlos R Figueiredo1 Liverpool Ocular Oncology Research Group, Department of Molecular & Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, UK
,
Judy M Coulson1 Liverpool Ocular Oncology Research Group, Department of Molecular & Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, UK;3 Department of Cellular & Molecular Physiology, Institute of Translational Medicine, University of Liverpool, UK
&
Sarah E Coupland1 Liverpool Ocular Oncology Research Group, Department of Molecular & Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, UK;4 Department of Cellular Pathology, Royal Liverpool University Hospital, Liverpool, UKCorrespondence[email protected]
Pages 1335-1338 | Received 07 Feb 2018, Accepted 21 Feb 2018, Published online: 09 May 2018

References

  • Heppt MV , SteebT, SchlagerJGet al. Immune checkpoint blockade for unresectable or metastatic uveal melanoma: a systematic review. Cancer Treat. Rev.60, 44–52 (2017).
  • Heppt MV , HeinzerlingL, KahlerKCet al. Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition. Eur. J. Cancer82, 56–65 (2017).
  • Shoushtari AN , Navid-AzarbaijaniP, FriedmanCFet al. Efficacy of nivolumab and ipilimumab (nivo + ipi) combination in melanoma patients (pts) treated at a single institution on an expanded-access program (EAP). J. Clin. Oncol.34, 9554–9554 (2016).
  • Robertson AG , ShihJ, YauCet al. Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell32, 204–220.e215 (2017).
  • Krishna Y , McCarthyC, KaliraiHet al. Inflammatory cell infiltrates in advanced metastatic uveal melanoma. Hum. Pathol.66, 159–166 (2017).
  • Javed A , ArguelloD, JohnstonCet al. PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma. Immunotherapy9, 1323–1330 (2017).
  • Qin Y , Petaccia de MacedoM, ReubenAet al. Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: a pilot study. Oncoimmunology6, e1321187 (2017).
  • Chandran SS , SomervilleRPT, YangJCet al. Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, Phase 2 study. Lancet Oncol.18, 792–802 (2017).
  • Carvajal R , SatoT, ShoushtariAet al. Safety, efficacy and biology of the gp100 TCR-based bispecific T cell redirector, IMCgp100 in advanced uveal melanoma in two Phase 1 trials. J. Immunother. Cancer5, P208 (2017).
  • Ambrosini G , PratilasCA, QinLXet al. Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance. Clin. Cancer Res.18, 3552–3561 (2012).
  • Carvajal RD , SosmanJA, QuevedoJFet al. Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. JAMA311, 2397–2405 (2014).
  • Holt SV , LogieA, OdedraRet al. The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models. Br. J. Cancer106, 858–866 (2012).
  • MacKeigan JP , CollinsTS, TingJP. MEK inhibition enhances paclitaxel-induced tumor apoptosis. J. Biol. Chem.275, 38953–38956 (2000).
  • Williams MD , EsmaeliB, SoheiliAet al. GPNMB expression in uveal melanoma: a potential for targeted therapy. Melanoma Res.20, 184–190 (2010).
  • Patel S , LewisK, OlenckiTet al. A Phase II study of glembatumumab vedotin for metastatic uveal melanoma. Presented at: 14th International Congress of the Society for Melanoma Research. Brisbane, Australia, 18–21 October 2017.
  • Hughes MS , ZagerJ, FariesMet al. Results of a randomized controlled multicenter Phase III trial of percutaneous hepatic perfusion compared with best available care for patients with melanoma liver metastases. Ann. Surg. Oncol.23, 1309–1319 (2016).
  • Karydis I , GangiA, WheaterMJet al. Percutaneous hepatic perfusion with melphalan in uveal melanoma: a safe and effective treatment modality in an orphan disease. J. Surg. Oncol.117, 1170–1178 (2018).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.